The UK’s mergers and acquisitions regulator the Takeover Panel has reportedly posted an annual loss of about $2.7 million due to a fall in deal making and costs related to an international panel recently held.
According to reports, UK’s global M&A performance has fallen short of expectations despite the recent high-profile acquisition approach of AstraZeneca by Pfizer.
Further, an event held last May for global merger regulators also bit into costs as the Panel spent about $2.5 million more on the conference than in previous years.
The UK’s Takeover Panel makes money through merger document fees and taxes for high-cost share acquisitions.
Full content: The Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
